Satellos Bioscience MSCLF Stock
Satellos Bioscience Price Chart
Satellos Bioscience MSCLF Financial and Trading Overview
| Satellos Bioscience stock price | 12.14 USD |
| Previous Close | 11.55 USD |
| Open | 0.88 USD |
| Bid | 0.9 USD x 1300000 |
| Ask | 0.94 USD x 400000 |
| Day's Range | 0.88 - 0.94 USD |
| 52 Week Range | 0.88 - 12.5 USD |
| Volume | 33.6K USD |
| Avg. Volume | 12.13K USD |
| Market Cap | 187.67M USD |
| Beta (5Y Monthly) | 0.712 |
| PE Ratio (TTM) | 4.723736 |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MSCLF Valuation Measures
| Enterprise Value | 145.22M USD |
| Trailing P/E | 4.723736 |
| Forward P/E | -55.18182 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 5.5081673 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -6.04 |
Trading Information
Satellos Bioscience Stock Price History
| Beta (5Y Monthly) | 0.712 |
| 52-Week Change | 90.52% |
| S&P500 52-Week Change | 32.69% |
| 52 Week High | 12.5 USD |
| 52 Week Low | 0.88 USD |
| 50-Day Moving Average | 7.34 USD |
| 200-Day Moving Average | 6.08 USD |
MSCLF Share Statistics
| Avg. Volume (3 month) | 12.13K USD |
| Avg. Daily Volume (10-Days) | 19.84K USD |
| Shares Outstanding | 15.46M |
| Float | 13.05M |
| Short Ratio | N/A |
| % Held by Insiders | 8.30% |
| % Held by Institutions | 8.23% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | September 30, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -54.25% |
| Return on Equity (ttm) | -87.59% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -16684621 USD |
| EBITDA | -24042894 USD |
| Net Income Avi to Common (ttm) | -21565172 USD |
| Diluted EPS (ttm) | 2.57 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 34.61M USD |
| Total Cash Per Share (mrq) | 2.24 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 10.704 |
| Book Value Per Share (mrq) | 2.204 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -21228352 USD |
| Levered Free Cash Flow (ttm) | -13990599 USD |
Profile of Satellos Bioscience
| Country | United States |
| State | ON |
| City | Toronto |
| Address | Royal Bank Plaza |
| ZIP | M5J 2J1 |
| Phone | N/A |
| Website | https://satellos.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 14 |
Satellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company uses its proprietary platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247 an oral, small-molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.
Q&A For Satellos Bioscience Stock
What is a current MSCLF stock price?
Satellos Bioscience MSCLF stock price today per share is 12.14 USD.
How to purchase Satellos Bioscience stock?
You can buy MSCLF shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Satellos Bioscience?
The stock symbol or ticker of Satellos Bioscience is MSCLF.
Which industry does the Satellos Bioscience company belong to?
The Satellos Bioscience industry is Biotechnology.
How many shares does Satellos Bioscience have in circulation?
The max supply of Satellos Bioscience shares is 15.46M.
What is Satellos Bioscience Price to Earnings Ratio (PE Ratio)?
Satellos Bioscience PE Ratio is 0.00000000 now.
What was Satellos Bioscience earnings per share over the trailing 12 months (TTM)?
Satellos Bioscience EPS is 0 USD over the trailing 12 months.
Which sector does the Satellos Bioscience company belong to?
The Satellos Bioscience sector is Healthcare.